APA (7th ed.) Citation

Davarci, G., Wängler, C., Eberhardt, K., Tulessin, M., Geppert, C., Schirrmacher, R., . . . Wängler, B. (2025). Preclinical evaluation of stable integrin αvβ3-specific (198Au)gold nanoparticles for tumor therapy. Pharmaceuticals, 18(11), . https://doi.org/10.3390/ph18111670

Chicago Style (17th ed.) Citation

Davarci, Güllü, et al. "Preclinical Evaluation of Stable Integrin αvβ3-specific (198Au)gold Nanoparticles for Tumor Therapy." Pharmaceuticals 18, no. 11 (2025). https://doi.org/10.3390/ph18111670.

MLA (9th ed.) Citation

Davarci, Güllü, et al. "Preclinical Evaluation of Stable Integrin αvβ3-specific (198Au)gold Nanoparticles for Tumor Therapy." Pharmaceuticals, vol. 18, no. 11, 2025, https://doi.org/10.3390/ph18111670.